Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ZNTL holding history

Zentalis Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ZNTL overviewAll 13F holders of ZNTLFull Q2 2026 holdings

Shares (Q2 2026)
546,566
Value
$2.65M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of ZNTL by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026546,566$2.65M<0.1%−937,532−63.2%ReducedHolders
Q1 20261,484,098$3.47M<0.1%−176,280−10.6%ReducedHolders
Q4 20251,660,378$2.24M<0.1%+251,575+17.9%AddedHolders
Q3 20251,408,803$2.13M<0.1%+211,179+17.6%AddedHolders
Q2 20251,197,624$1.39M<0.1%+79,847+7.1%AddedHolders
Q1 20251,117,777$1.78M<0.1%−121,682−9.8%ReducedHolders
Q4 20241,239,459$3.76M<0.1%+110,882+9.8%AddedHolders
Q3 20241,128,577$4.15M<0.1%+888,236+369.6%AddedHolders
Q2 2024240,341$983.0K<0.1%+226,050+1,581.8%AddedHolders
Q1 202414,291$225.2K<0.1%+14,291NewHolders
Q4 20230$00.0%−37,439−100.0%Sold outHolders
Q3 202337,439$751.0K<0.1%+37,439NewHolders
Q4 20220$00.0%−29,112−100.0%Sold outHolders
Q3 202229,112$631.0K<0.1%−25,633−46.8%ReducedHolders
Q2 202254,745$1.54M<0.1%+33,786+161.2%AddedHolders
Q1 202220,959$967.0K<0.1%+2,867+15.8%AddedHolders
Q4 202118,092$1.52M<0.1%−36,346−66.8%ReducedHolders
Q3 202154,438$3.63M<0.1%−2,016−3.6%ReducedHolders
Q2 202156,454$3.00M<0.1%+34,283+154.6%AddedHolders
Q1 202122,171$962.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.